Portable Biosensors and Point-of-Care Systems describes the principles, design and applications of a new generation of analytical and diagnostic biomedical devices, characterized by their very small size, ease of use, multi-analytical capabilities and speed to provide handheld and mobile point-of-care (POC) diagnostics. The book is divided in four Parts. Part I is an in-depth analysis of the various technologies upon which portable diagnostic devices and biosensors are built. In Part II, advances in the design and optimization of special components of biosensor systems and handheld devices are presented. In Part III, a wide scope of applications of portable biosensors and handheld POC devices is described, ranging from the support of primary healthcare to food and environmental safety screening. Diverse topics are covered, including counterterrorism, travel medicine and drug development. Finally, Part IV of the book is dedicated to the presentation of commercially available products including a review of the products of point-of-care in-vitro-diagnostics companies, a review of technologies which have achieved a high Technology Readiness Level, and a special market case study of POC infusion systems combined with intelligent patient monitoring. This book is essential reading for researchers and experts in the healthcare diagnostic and analytical sector, and for electronics and material engineers working on portable sensors.

Plants that Fight Cancer, Second Edition, is a compilation that reviews cancer treatment and research-based information on the plant kingdom as the source of both known and novel chemical moieties and mixtures, many of them still under identification. This new edition follows the organization of the first book with a considerable expansion of content that more than doubles the volume of information. Divided into four segments, the first part is dedicated to a review of our current knowledge of cancer, the different types and incidence, the molecular pathways of the disease, and the various treatment protocols, with an emphasis on chemotherapy. The second part is a brief journey in pharmacognosy, with detailed information about each of the fourteen different chemical groups of plant secondary metabolites, their use in cancer chemotherapy, and updated information on the biotechnological production of the most representative compounds in clinical practice. The third part of the book comprises six chapters dedicated to either plant chemotherapeutical approaches to specific cancer types (e.g. bladder, prostate) or specific groups of plant secondary metabolites with novel and promising properties for cancer treatment (e.g. naphthoquinones, lectins, phenanthridone alkaloids). The fourth part, containing investigative information on almost 300 individual plant species with established anticancer properties, either on a clinical or in vitro level, is with no doubt the most analytical. This new edition contains chapters on cytotoxic phenanthridone alkaloid constituents of the Amaryllidaceae; naphthoquinone-contained anticancer terrestrial plants; polyphenols and cancer immunology; medicinal plant product-based fabrication nanoparticles (Au and Ag) and their anticancer effects; bladder and prostate cancer; and plant lectins in cancer treatment. FEATURES * Provides efficient information for all kinds of cancer and plant chemotherapeutical approaches to specific cancer types * Discusses specific groups of plant secondary metabolites with novel and promising properties for cancer treatment * Provides scientific information for medicinal uses of various plants * Contains analytical information on almost 300 individual plant species with established anticancer properties, either on a clinical or in vitro level * Focuses on plant genera and species that are either already used in cancer chemotherapy or have been identified with antitumor and antileukemic properties to a bigger or lesser extent

Plants that Fight Cancer, Second Edition, is a compilation that reviews cancer treatment and research-based information on the plant kingdom as the source of both known and novel chemical moieties and mixtures, many of them still under identification. This new edition follows the organization of the first book with a considerable expansion of content that more than doubles the volume of information. Divided into four segments, the first part is dedicated to a review of our current knowledge of cancer, the different types and incidence, the molecular pathways of the disease, and the various treatment protocols, with an emphasis on chemotherapy. The second part is a brief journey in pharmacognosy, with detailed information about each of the fourteen different chemical groups of plant secondary metabolites, their use in cancer chemotherapy, and updated information on the biotechnological production of the most representative compounds in clinical practice. The third part of the book comprises six chapters dedicated to either plant chemotherapeutical approaches to specific cancer types (e.g. bladder, prostate) or specific groups of plant secondary metabolites with novel and promising properties for cancer treatment (e.g. naphthoquinones, lectins, phenanthridone alkaloids). The fourth part, containing investigative information on almost 300 individual plant species with established anticancer properties, either on a clinical or in vitro level, is with no doubt the most analytical. This new edition contains chapters on cytotoxic phenanthridone alkaloid constituents of the Amaryllidaceae; naphthoquinone-contained anticancer terrestrial plants; polyphenols and cancer immunology; medicinal plant product-based fabrication nanoparticles (Au and Ag) and their anticancer effects; bladder and prostate cancer; and plant lectins in cancer treatment. FEATURES * Provides efficient information for all kinds of cancer and plant chemotherapeutical approaches to specific cancer types * Discusses specific groups of plant secondary metabolites with novel and promising properties for cancer treatment * Provides scientific information for medicinal uses of various plants * Contains analytical information on almost 300 individual plant species with established anticancer properties, either on a clinical or in vitro level * Focuses on plant genera and species that are either already used in cancer chemotherapy or have been identified with antitumor and antileukemic properties to a bigger or lesser extent